Last 27 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -27.47 | 26.20 | 8.58 | — | — | — | — | — | — | 30.75 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.26 | 0.96 | 0.31 | 0.62 | 0.79 | 0.74 | 0.96 | 1.15 | 1.04 | 0.43 | 0.32 | 0.22 | 0.42 | 0.34 | 0.31 | 0.12 | 0.24 | 0.30 | 0.48 | 1.01 | 1.82 |
| — | +29.4% | -67.6% | -45.8% | -24.4% | +73.9% | +197.2% | +411.7% | +146.1% | +27.3% | +3.3% | +81.8% | +79.0% | +11.6% | -34.6% | -87.8% | -87.0% | -90.9% | -86.5% | -90.1% | -75.6% | |
| P/B Ratio | 7.82 | 7.60 | 2.76 | 3.94 | 4.60 | 4.13 | 5.31 | 4.54 | 4.04 | 1.87 | 1.54 | 1.60 | 1.61 | 1.30 | 1.25 | 1.24 | 2.07 | 2.39 | 3.43 | 3.25 | 7.54 |
| — | +84.1% | -48.0% | -13.3% | +13.9% | +120.0% | +244.7% | +183.7% | +150.4% | +44.2% | +23.0% | +28.6% | -22.1% | -45.5% | -63.5% | -61.7% | -72.5% | -86.2% | -29.0% | — | — | |
| P/FCF | — | 29.16 | 2.19 | — | 34.37 | 73.35 | — | — | 6.97 | 3.43 | 4.42 | — | — | 2.03 | 1.28 | — | 2.00 | — | — | — | — |
| — | -60.3% | — | — | +393.2% | +2037.0% | — | — | — | +68.7% | +244.1% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 23.27 | 6.86 | — | — | — | — | — | — | 11.92 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 23.74 | 6.99 | — | — | — | — | — | — | 12.49 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.5% | 20.6% | 21.3% | 15.2% | 14.7% | 20.9% | 23.6% | 27.9% | 24.5% | 30.3% | 23.6% | 12.2% | 23.0% | 23.7% | 14.7% | 0.6% | 2.0% | -1.4% | 1.4% | -2.3% | -2.1% |
| — | -1.3% | -9.6% | -45.4% | -40.0% | -31.1% | -0.1% | +128.4% | +6.9% | +27.8% | +60.8% | +2031.5% | +1055.6% | +1760.4% | +912.8% | +125.3% | +192.6% | +87.2% | +120.6% | +71.8% | -115.0% | |
| Operating Margin | -4.4% | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.4% | -2.7% | 2.0% | -6.5% | -12.9% | -11.0% | -9.0% | -24.8% | -11.9% | -8.6% | -12.1% | -10.0% | -43.2% | -34.9% |
| — | +270.4% | +1423.8% | -58.9% | -84.9% | -209.6% | +95.8% | +50.5% | +75.8% | +122.4% | +73.6% | -7.9% | -27.0% | +25.6% | -147.4% | +72.4% | +75.2% | +72.5% | +83.2% | -6.3% | -173.3% | |
| Net Margin | -4.4% | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.6% | -2.8% | 2.1% | -5.5% | -13.8% | -13.6% | -9.0% | -22.5% | -9.4% | -8.8% | -12.3% | -8.6% | -43.3% | -8.1% |
| — | +270.1% | +1423.8% | -54.2% | -77.5% | -206.5% | +95.0% | +52.5% | +79.6% | +123.1% | +75.5% | -47.7% | -53.8% | +27.0% | -161.2% | +78.4% | -9.0% | +84.0% | +64.3% | +43.0% | -207.1% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -26.3% | 7.8% | 8.4% | -15.2% | -7.1% | -3.1% | -0.4% | -6.5% | -2.7% | 2.4% | -6.6% | -23.2% | -12.7% | -8.8% | -21.4% | -22.4% | -18.4% | -22.8% | -14.7% | -39.3% | -9.5% |
| — | +351.6% | +2342.1% | -134.8% | -159.3% | -229.6% | +94.3% | +72.1% | +78.4% | +127.2% | +69.0% | -3.2% | +31.0% | +61.3% | -45.6% | +42.9% | -94.1% | +67.6% | -78.5% | — | — | |
| ROA | -15.3% | 3.9% | 4.4% | -9.0% | -4.3% | -1.8% | -0.2% | -3.6% | -1.4% | 1.1% | -3.1% | -8.6% | -3.6% | -2.1% | -6.4% | -7.1% | -4.2% | -4.4% | -4.2% | -19.7% | -3.2% |
| — | +316.3% | +2117.0% | -150.2% | -211.5% | -265.9% | +92.9% | +58.6% | +61.4% | +151.8% | +51.9% | -21.7% | +14.2% | +51.7% | -54.4% | +63.9% | -30.9% | +85.6% | +51.3% | +53.8% | -181.9% | |
| ROIC | -34.0% | 12.2% | 10.3% | -19.4% | -11.9% | -4.7% | -0.6% | -15.7% | -10.0% | 6.6% | -12.9% | -48.6% | -94.0% | -26.4% | -30.1% | -54.6% | -67.6% | -34.0% | -22.2% | -55.4% | -231.4% |
| — | +359.5% | +1870.4% | -23.3% | -19.5% | -171.1% | +95.5% | +67.7% | +89.4% | +125.1% | +57.0% | +10.9% | -39.1% | +22.4% | -35.6% | +1.4% | +70.8% | +87.7% | — | — | -417.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.07 | 0.06 | 0.22 | 0.05 | 0.07 |
| — | — | — | — | — | — | — | — | -30.5% | -23.8% | -16.9% | -0.8% | -77.0% | -74.0% | -91.9% | -68.2% | -3.1% | -32.6% | +132.8% | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | 0.53 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.47 | 1.50 | 1.33 | 1.47 | 1.71 | 1.80 | 1.54 | 1.61 | 1.55 | 1.69 | 1.55 | 1.64 | 1.27 | 1.24 | 1.15 | 1.45 | 1.29 | 1.16 | 1.16 | 2.02 | 2.43 |
| — | -16.5% | -13.4% | -8.3% | +10.5% | +6.1% | -0.9% | -2.0% | +21.5% | +36.2% | +35.1% | +13.2% | -1.5% | +6.8% | -0.9% | -28.3% | -46.7% | -68.2% | -75.3% | +74.8% | — | |
| Quick Ratio | 1.47 | 1.50 | 1.33 | 1.47 | 1.71 | 1.80 | 1.54 | 1.61 | 1.55 | 1.69 | 1.55 | 1.64 | 1.27 | 1.24 | 1.15 | 1.45 | 1.29 | 1.16 | 1.16 | 2.02 | 2.43 |
| — | -16.5% | -13.4% | -8.3% | +10.5% | +6.1% | -0.9% | -2.0% | +21.5% | +36.2% | +35.1% | +13.2% | -1.5% | +6.8% | -0.9% | -28.3% | -46.7% | -68.2% | -75.3% | +74.8% | — | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | -4126.00 | — | -603.65 | -181.78 | -254.79 | -186.32 | -453.37 | -80.05 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 27 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CLOV stock.
Clover Health Investments, Corp.'s current P/E is -27.5x. The average P/E over the last 2 quarters is 17.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Clover Health Investments, Corp.'s current operating margin is -4.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Clover Health Investments, Corp.'s business trajectory between earnings reports.